Literature DB >> 18802051

Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta.

Aileen G Rowan1, Jean M Fletcher, Elizabeth J Ryan, Barry Moran, John E Hegarty, Cliona O'Farrelly, Kingston H G Mills.   

Abstract

IL-17-secreting T (Th17) cells play a protective role in certain bacterial infections, but they are major mediators of inflammation and are pathogenic in organ-specific autoimmune diseases. However, human Th17 cells appear to be resistant to suppression by CD4(+)CD25(+)FoxP3(+) regulatory T cells, suggesting that they may be regulated by alternative mechanisms. Herein we show that IL-10 and TGF-beta suppressed IL-17 production by anti-CD3-stimulated PBMC from normal individuals. TGF-beta also suppressed IL-17 production by purified CD4(+) T cells, whereas the inhibitory effect of IL-10 on IL-17 production appears to be mediated predominantly by its effect on APC. An examination of patients infected with hepatitis C virus (HCV) demonstrated that Ag-specific Th17 cells are induced during infection and that these cells are regulated by IL-10 and TGF-beta. PBMC from HCV Ab-positive donors secreted IL-17, IFN-gamma, IL-10, and TGF-beta in response to stimulation with the HCV nonstructural protein 4 (NS4). Furthermore, NS4 induced innate TGF-beta and IL-10 expression by monocytes from normal donors and at higher levels from HCV-infected patients. Neutralization of TGF-beta, and to a lesser extent IL-10, significantly enhanced NS4-specific IL-17 and IFN-gamma production by T cells from HCV-infected donors. Our findings suggest that both HCV-specific Th1 and Th17 cells are suppressed by NS4-induced production of the innate anti-inflammatory cytokines IL-10 and TGF-beta. This may represent a novel immune subversion mechanism by the virus to evade host-protective immune responses. Our findings also suggest that TGF-beta and IL-10 play important roles in constraining the function of Th17 cells in general.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802051     DOI: 10.4049/jimmunol.181.7.4485

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

1.  Development of autoimmune diabetes in the absence of detectable IL-17A in a CD8-driven virally induced model.

Authors:  Tom L Van Belle; Enric Esplugues; Jeanette Liao; Therese Juntti; Richard A Flavell; Matthias G von Herrath
Journal:  J Immunol       Date:  2011-08-10       Impact factor: 5.422

Review 2.  Adaptive immunity to the hepatitis C virus.

Authors:  Christopher M Walker
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

Review 3.  Non-Hodgkin lymphoma and hepatitis C: where we are and what next?

Authors:  Mihály Sulyok; Mihály Makara; Eszter Újhelyi; István Vályi-Nagy
Journal:  Pathol Oncol Res       Date:  2014-10-02       Impact factor: 3.201

4.  Differential regulation of interleukin-12 (IL-12)/IL-23 by Tim-3 drives T(H)17 cell development during hepatitis C virus infection.

Authors:  Jia M Wang; Lei Shi; Cheng J Ma; Xiao J Ji; Ruo S Ying; Xiao Y Wu; Ke S Wang; Guangyu Li; Jonathan P Moorman; Zhi Q Yao
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

5.  Acute hepatitis C virus infection in a nurse trainee following a needlestick injury.

Authors:  Renzo Scaggiante; Liliana Chemello; Roberto Rinaldi; Giovanni Battista Bartolucci; Andrea Trevisan
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

6.  T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis.

Authors:  Pascal Feunou Feunou; Julie Bertout; Camille Locht
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

7.  Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment.

Authors:  Ji-Yuan Zhang; Chun-Hui Song; Feng Shi; Zheng Zhang; Jun-Liang Fu; Fu-Sheng Wang
Journal:  PLoS One       Date:  2010-11-08       Impact factor: 3.240

8.  Chronic ethanol diet increases regulatory T-cell activity and inhibits hepatitis C virus core-specific cellular immune responses in mice.

Authors:  Vivian Ortiz; Jack R Wands
Journal:  Hepatol Res       Date:  2013-07-04       Impact factor: 4.288

9.  Hepatitis C virus promotes T-helper (Th)17 responses through thymic stromal lymphopoietin production by infected hepatocytes.

Authors:  Hai-Chon Lee; Sung-Sang J Sung; Peter D Krueger; Yoon-Ah Jo; Hugo R Rosen; Steven F Ziegler; Young S Hahn
Journal:  Hepatology       Date:  2013-03-14       Impact factor: 17.425

10.  Contribution of IL-17 to mouse hepatitis virus strain 3-induced acute liver failure.

Authors:  Lin Zhu; Tao Chen; Yulei Lu; Di Wu; Xiaoping Luo; Qin Ning
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.